SCHEMBL3726052

SCHEMBL3726052

CCN(C(C)=O)c1nc(C)cc(OP(O)(O)=S)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.49
ALDH1A1 P00352 3/20 0.36
TSHR P16473 3/20 0.36
CYP3A4 P08684 3/20 0.36
HSD17B10 Q99714 3/20 0.36
TP53 P04637 1/20 0.36
ACHE P22303 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
POLQ O75417 3/20 0.36
HTT P42858 3/20 0.34
CRHR1 P34998 1/20 0.32
CYP1A2 P05177 3/20 0.32
HCRTR1 O43613 2/20 0.32
HCRTR2 O43614 2/20 0.32
CYP2C19 P33261 2/20 0.32
MEN1 O00255 1/20 0.32
RECQL P46063 1/20 0.32
KMT2A Q03164 1/20 0.32
LMNA P02545 1/20 0.30
CYP2D6 P10635 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL120557 0.86 TDP1 (0.69) TDP1ALDH1A1TSHRCYP3A4HSD17B10
SCHEMBL1901390 0.82 TDP1 (0.70) TDP1ALDH1A1TSHRCYP3A4HSD17B10
Pirimiphos Methyl SCHEMBL7081499 0.79 TDP1 (0.71) TDP1ALDH1A1TSHRCYP3A4HSD17B10
Pirimiphos-Ethyl SCHEMBL5266465 0.76 TDP1 (0.66) TDP1ALDH1A1TSHRCYP3A4HSD17B10
SCHEMBL500245 0.72 TDP1 (0.43) TDP1ALDH1A1TSHRCYP3A4HSD17B10
Pirimiphos Methyl SCHEMBL21357930 0.70 TDP1 (0.68) TDP1ALDH1A1TSHRCYP3A4HSD17B10
SCHEMBL8976690 0.69 TDP1 (0.59) TDP1ALDH1A1TSHRCYP3A4HSD17B10
SCHEMBL10109500 0.69 TDP1 (0.67) TDP1ALDH1A1TSHRCYP3A4HSD17B10
Propane SCHEMBL10919258 0.68 TDP1 (0.61) TDP1ALDH1A1TSHRCYP3A4HSD17B10
Pyrimitate SCHEMBL7870561 0.68 TDP1 (0.68) TDP1ALDH1A1TSHRCYP3A4HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100168030-A1 Methods and compositions for treatment of organophosphate-caused pathology ARMY, UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE 2010-07-01 US disclosed